4D label-free proteomics analysis of oxygen-induced retinopathy with or without anti-VEGF treatment

[1]  T. Oshika,et al.  Comparison of long-term treatment outcomes of laser and anti-VEGF therapy in retinopathy of prematurity: a multicentre study from J-CREST group , 2023, Eye.

[2]  A. Stahl,et al.  Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial. , 2022, JAMA.

[3]  L. Filippi,et al.  Neurosensory Alterations in Retinopathy of Prematurity: A Window to Neurological Impairments Associated to Preterm Birth , 2022, Biomedicines.

[4]  Jing Zhang,et al.  Advances in the study of RNA-binding proteins in diabetic complications , 2022, Molecular metabolism.

[5]  C. Barnstable,et al.  Novel Regulators of Retina Neovascularization: A Proteomics Approach. , 2021, Journal of proteome research.

[6]  M. Cammalleri,et al.  An imbalance in autophagy contributes to retinal damage in a rat model of oxygen‐induced retinopathy , 2021, Journal of cellular and molecular medicine.

[7]  Peiquan Zhao,et al.  Competing endogenous RNA network associated with oxygen-induced retinopathy: expression of the network and identification of the MALAT1/miR-124-3p/EGR1 regulatory axis. , 2021, Experimental cell research.

[8]  S. Yoshida,et al.  Metabolomics Analyses of Mouse Retinas in Oxygen-Induced Retinopathy , 2021, Investigative ophthalmology & visual science.

[9]  M. Fabbri,et al.  Noncoding RNA therapeutics — challenges and potential solutions , 2021, Nature reviews. Drug discovery.

[10]  R. Gallemore,et al.  Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options , 2021, Cells.

[11]  E. Chang,et al.  80 Years of vision: preventing blindness from retinopathy of prematurity , 2021, Journal of Perinatology.

[12]  Akiyoshi Uemura,et al.  VEGFR1 signaling in retinal angiogenesis and microinflammation , 2021, Progress in Retinal and Eye Research.

[13]  Y. Di,et al.  Effects of long non-coding RNA myocardial infarction-associated transcript on retinal neovascularization in a newborn mouse model of oxygen-induced retinopathy , 2021, Neural regeneration research.

[14]  Lei Zhou,et al.  Proteomic analysis of aqueous humor in patients with pathologic myopia. , 2020, Journal of proteomics.

[15]  S. Joachim,et al.  Minocycline reduces inflammatory response and cell death in a S100B retina degeneration model , 2020, Journal of neuroinflammation.

[16]  J. Valcárcel,et al.  RNA-binding proteins in human genetic disease , 2020, Nature reviews. Genetics.

[17]  M. Montecino,et al.  Functional Diversification of SRSF Protein Kinase to Control Ubiquitin-Dependent Neurodevelopmental Signaling , 2020, Developmental cell.

[18]  Bo-Eun Yoon,et al.  Neuron-Glia Interactions in Neurodevelopmental Disorders , 2020, Cells.

[19]  G. Li Volti,et al.  Oxidative Stress Markers and the Retinopathy of Prematurity , 2020, Journal of clinical medicine.

[20]  Y. Di,et al.  Effect and mechanism of the long noncoding RNA MALAT1 on retinal neovascularization in retinopathy of prematurity. , 2020, Life sciences.

[21]  Yan Deng,et al.  CircPDE4B inhibits retinal pathological angiogenesis via promoting degradation of HIF-1α though targeting miR-181c. , 2020, IUBMB life.

[22]  N. Sheibani,et al.  Long-term evaluation of retinal morphology and function in a mouse model of oxygen-induced retinopathy , 2020, Molecular vision.

[23]  R. D'Amato,et al.  MicroRNA-18a-5p Administration Suppresses Retinal Neovascularization by Targeting FGF1 and HIF1A , 2020, Frontiers in Pharmacology.

[24]  R. Backofen,et al.  Temporospatial distribution and transcriptional profile of retinal microglia in the oxygen‐induced retinopathy mouse model , 2020, Glia.

[25]  E. DeFranco,et al.  Regional Contribution of Previable Infant Deaths to Infant Mortality Rates in the United States , 2019, American Journal of Perinatology.

[26]  R. Higgins.  Oxygen Saturation and Retinopathy of Prematurity. , 2019, Clinics in perinatology.

[27]  X. Ji,et al.  Oxygen-induced circRNA profiles and coregulatory networks in a retinopathy of prematurity mouse model , 2019, Experimental and therapeutic medicine.

[28]  C. Fader,et al.  Effect of Autophagy Modulators on Vascular, Glial, and Neuronal Alterations in the Oxygen-Induced Retinopathy Mouse Model , 2019, Front. Cell. Neurosci..

[29]  Gretchen A. Stevens,et al.  National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis , 2019, The Lancet. Global health.

[30]  J. Chen,et al.  MicroRNA-145 Regulates Pathological Retinal Angiogenesis by Suppression of TMOD3 , 2019, Molecular therapy. Nucleic acids.

[31]  Min Kim,et al.  Intravitreal ranibizumab versus laser photocoagulation for retinopathy of prematurity: efficacy, anatomical outcomes and safety , 2018, British Journal of Ophthalmology.

[32]  L. Baumbusch,et al.  An iTRAQ-Based Quantitative Proteomic Analysis of Plasma Proteins in Preterm Newborns With Retinopathy of Prematurity. , 2018, Investigative ophthalmology & visual science.

[33]  S. Banfi,et al.  Non-coding RNAs in retinal development and function , 2018, Human Genetics.

[34]  H. Uusitalo,et al.  SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets. , 2018, Investigative ophthalmology & visual science.

[35]  G. Bruno,et al.  Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective , 2017, International journal of molecular sciences.

[36]  K. Toyo-oka,et al.  14-3-3 Proteins in Brain Development: Neurogenesis, Neuronal Migration and Neuromorphogenesis , 2017, Front. Mol. Neurosci..

[37]  G. Quinn,et al.  Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective , 2017, Progress in Retinal and Eye Research.

[38]  Chaopeng Li,et al.  Silencing Of Circular RNA-ZNF609 Ameliorates Vascular Endothelial Dysfunction , 2017, Theranostics.

[39]  K. Sugioka,et al.  Identification of vitreous proteins in retinopathy of prematurity. , 2017, Biochemical and biophysical research communications.

[40]  A. Fawzi,et al.  Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption , 2016, PloS one.

[41]  S. Govoni,et al.  Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat. , 2016, Pharmacological research.

[42]  V. Danielisová,et al.  Neuroprotection and antioxidants , 2016, Neural regeneration research.

[43]  V. Bhat,et al.  Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. , 2016, The Cochrane database of systematic reviews.

[44]  Chang Sik Cho,et al.  Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors , 2014, Journal of Molecular Medicine.

[45]  T. Hla,et al.  Post-transcriptional gene regulation by HuR and microRNAs in angiogenesis , 2014, Current opinion in hematology.

[46]  D. Hinton,et al.  Novel roles for α-crystallins in retinal function and disease , 2012, Progress in Retinal and Eye Research.

[47]  Soo-Chen Cheng,et al.  Functional roles of protein splicing factors , 2012, Bioscience reports.

[48]  J. Casey,et al.  Recessive mutations in MCM4/PRKDC cause a novel syndrome involving a primary immunodeficiency and a disorder of DNA repair , 2012, Journal of Medical Genetics.

[49]  Seo-Hyun Choi,et al.  Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction , 2012, Angiogenesis.

[50]  S. McColley,et al.  Elevated vascular endothelial growth factor is correlated with elevated erythropoietin in stable, young cystic fibrosis patients , 2011, Pediatric pulmonology.

[51]  G. Sedin,et al.  Impact at Age 11 Years of Major Neonatal Morbidities in Children Born Extremely Preterm , 2011, Pediatrics.

[52]  Alice Z Chuang,et al.  Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. , 2011, The New England journal of medicine.

[53]  E. Fletcher,et al.  Characterization of retinal function and glial cell response in a mouse model of oxygen‐induced retinopathy , 2011, The Journal of comparative neurology.

[54]  Jing Chen,et al.  The mouse retina as an angiogenesis model. , 2010, Investigative ophthalmology & visual science.

[55]  G. Alton,et al.  Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function. , 2010, Investigative ophthalmology & visual science.

[56]  Andreas Stahl,et al.  Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis , 2009, Nature Protocols.

[57]  James D. Akula,et al.  The neurovascular retina in retinopathy of prematurity , 2009, Progress in Retinal and Eye Research.

[58]  M. Hartnett,et al.  The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model. , 2009, Investigative ophthalmology & visual science.

[59]  Lois E. H. Smith,et al.  Erythropoietin deficiency decreases vascular stability in mice. , 2008, The Journal of clinical investigation.

[60]  C. Schmitz,et al.  Hypoxia-regulated components of the U4/U6.U5 tri-small nuclear riboprotein complex: possible role in autosomal dominant retinitis pigmentosa , 2008, Molecular vision.

[61]  Fumio Hanaoka,et al.  Site‐specific phosphorylation of MCM4 during the cell cycle in mammalian cells , 2006, The FEBS journal.

[62]  S. Ryu,et al.  Depletion of minichromosome maintenance protein 5 in the zebrafish retina causes cell-cycle defect and apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  T. Gardner,et al.  Retinal angiogenesis in development and disease , 2005, Nature.

[64]  Y. Ishimi,et al.  Levels of MCM4 phosphorylation and DNA synthesis in DNA replication block checkpoint control. , 2004, Journal of structural biology.

[65]  M. Nakanishi,et al.  Identification of MCM4 as a Target of the DNA Replication Block Checkpoint System* , 2003, Journal of Biological Chemistry.

[66]  J. Provis.  Development of the Primate Retinal Vasculature , 2001, Progress in Retinal and Eye Research.

[67]  E. Bonanno,et al.  Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model , 2000, In Vitro Cellular & Developmental Biology - Animal.

[68]  M. Inagaki,et al.  Cell Cycle- and Chromatin Binding State-dependent Phosphorylation of Human MCM Heterohexameric Complexes , 1998, The Journal of Biological Chemistry.

[69]  P. Yurchenco,et al.  Modulation of angiogenesis in vitro by laminin-entactin complex. , 1994, Developmental biology.

[70]  M. Hartnett,et al.  Pathophysiology and mechanisms of severe retinopathy of prematurity. , 2015, Ophthalmology.

[71]  G. Siuzdak,et al.  Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen‐induced retinopathy , 2010, Glia.

[72]  E. Goldwasser,et al.  A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene. , 2000, Blood.